close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cardio Diagnostics Holdings Inc. - Common stock (NQ:CDIO)

3.095 +0.015 (+0.49%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cardio Diagnostics Holdings Inc. - Common stock

News headline image
Cardio Diagnostics Holdings, Inc. to Showcase HeartRisk and Actionable Clinical Intelligence Version 3 at the American College of Cardiology’s 73rd Annual Scientific Session
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
News headline image
BlackRock Bolsters Wealth Management Arsenal With SpiderRock Advisors Acquisition, Expanding SMA Solutions ↗
BlackRock (NYSE: BLK) to acquire full ownership of SpiderRock Advisors, expanding offerings in customized option overlay strategies for U.S. wealth market. 
Via Benzinga
News headline image
Cardio Diagnostics Holdings, Inc. Announces Issuance of Second U.S. Patent for Compositions and Methods for Detecting Predisposition to Cardiovascular Disease
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
BlackRock Acquires Stake In Cardio Diagnostics
--News Direct-- 
Via News Direct
News headline image
Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Cardio Diagnostics Holdings, Inc. Expands HeartRisk™ Platform Offering to Diverse Markets in Conjunction with Nationwide Rollout
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
Cardio Diagnostics (NASDAQ: CDIO) Expands Partnership With Family Medicine Specialists To Bring Specialty Cardiology Tests To Select Walmart Supercenters
--News Direct-- 
Via News Direct
News headline image
Cardio Diagnostics (NASDAQ: CDIO) Expands Partnership With Family Medicine Specialists To Bring Specialty Cardiology Tests To Select Walmart Supercenters ↗
A precision cardiovascular medicine company’s innovative AI-driven epigenetic-genetic blood tests will soon be available in one of the nation’s largest retailers. 
Via Benzinga
News headline image
BlackRock Acquires Stake In Cardio Diagnostics ↗
BlackRock (NYSE: BLK) has acquired a minor stake in Cardio Diagnostics (NASDAQ: CDIO), an artificial intelligence-powered precision cardiovascular medicine company. In BlackRock’s 13G filing on Feb. 
Via Benzinga
News headline image
Cardio Diagnostics Holdings, Inc. Expands Partnership with Family Medicine Specialists to Bring Its Specialty Cardiology Tests to Select Walmart Supercenters
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
News headline image
Houston-Based resTOR Longevity Clinic to Offer Cardio Diagnostics' AI-Driven Epigenetic-Genetic Heart Disease Tests
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
American Medical Association Grants Cardio Diagnostics (NASDAQ: CDIO) Reimbursement Codes For AI-Powered Coronary Heart Disease Tests
By Jeremy Golden, Benzinga 
Via TheNewswire.com
Topics Death
American Medical Association Grants Cardio Diagnostics (NASDAQ: CDIO) Reimbursement Codes For AI-Powered Coronary Heart Disease Tests
--News Direct-- 
Via News Direct
News headline image
American Medical Association Grants Cardio Diagnostics (NASDAQ: CDIO) Reimbursement Codes For AI-Powered Coronary Heart Disease Tests ↗
Cardio Diagnostics’ AI-driven coronary heart disease (CHD) tests have taken another promising step in their evolution. 
Via Benzinga
News headline image
Cardio Diagnostics Holdings, Inc. Accelerates Cardiac Care Innovation with Appointment of Dr. Vimal Ramjee as Strategic Advisor
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
Beyond Diagnosis: Cardio Diagnostics' Actionable Clinical Intelligence Platform Provides Personalized Insights To Help Prevent Heart Attacks
By Jeremy Golden, Benzinga 
Via TheNewswire.com
Beyond Diagnosis: Cardio Diagnostics' Actionable Clinical Intelligence Platform Provides Personalized Insights To Help Prevent Heart Attacks
--News Direct-- 
Via News Direct
News headline image
Cardio Diagnostics Holdings, Inc. Announces the Grant of a Patent in India
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
News headline image
Beyond Diagnosis: Cardio Diagnostics' Actionable Clinical Intelligence Platform Provides Personalized Insights To Help Prevent Heart Attacks ↗
An artificial intelligence-powered precision cardiovascular medicine company named Cardio Diagnostics (NASDAQ: CDIO) has launched a first-of-its-kind platform called 
Via Benzinga
News headline image
CORRECTING and REPLACING Cardio Diagnostics Holdings, Inc. Unveils Groundbreaking Employer Cardiovascular Disease Risk Intelligence Platform, HeartRisk™
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
News headline image
American Medical Association (AMA) Grants Cardio Diagnostics a Dedicated CPT PLA Reimbursement Code for Epi+Gen CHD, an AI-powered Test for Assessing the Probability of a Heart Attack or Coronary Heart Disease Event
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Why Cardio Diagnostics Holdings Stock Is Racing Higher ↗
Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) shares are rocketing higher Tuesday after the company announced that the American Medical Association (AMA) has assigned a dedicated Current Procedural... 
Via Benzinga
News headline image
American Medical Association (AMA) Grants Cardio Diagnostics Holdings, Inc.’s AI-Powered Coronary Heart Disease Detection Test, PrecisionCHD, a Dedicated CPT PLA Reimbursement Code
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
News headline image
Cardio Diagnostics Holdings, Inc. Appoints Biotechnology Investor, Executive & Serial Entrepreneur Paul Burton to its Board of Directors
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
Cardio Diagnostics’ Breakthrough Coronary Heart Disease Detection Test Published In The Journal Of The American Heart Association
--News Direct-- 
Via News Direct
Cardio Diagnostics’ Breakthrough Coronary Heart Disease Detection Test Published In The Journal Of The American Heart Association
By Jeremy Golden, Benzinga 
Via TheNewswire.com
News headline image
Cardio Diagnostics' Breakthrough Coronary Heart Disease Detection Test Published In The Journal Of The American Heart Association ↗
Cardio Diagnostics (NASDAQ: CDIO), a leader in artificial intelligence-driven precision cardiovascular medicine, has published a potentially revolutionary study in the Journal of the American Heart... 
Via Benzinga
News headline image
Cardio Diagnostics Holdings, Inc. Regains Nasdaq Minimum Bid Price Requirement
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today